Mr. Ryan Roebuck reports

APOLO V ACQUISITION CORP. ANNOUNCES SHAREHOLDER APPROVALS

Apolo V Acquisition Corp. has released the voting results from its special meeting of shareholders held on Thursday, March 5, 2026, in connection with its previously announced proposed qualifying transaction with TelyRx Inc.

All matters put forth at the Apolo meeting, including: (i) the election of directors of the company, conditional upon and effective as of the completion of the proposed qualifying transaction; (ii) the approval of the amendment of the articles of Apolo to change the name of the company to TelyRx Holdings Inc. or such other name as TelyRx may reasonably determine; (iii) the approval to consolidate the common shares of Apolo at a consolidation ratio between a range of one postconsolidation common share for every 20 preconsolidation common shares and one postconsolidation common share for every 60 preconsolidation common shares; (iv) the approval of the amendment of the articles of Apolo to effect a share capital reorganization including to: (a) attach special rights and restrictions to the common shares and change the identifying name of the common shares to subordinate voting shares; and (b) create a new class of shares, the proportionate voting shares; (v) to approve an omnibus equity incentive plan to be adopted by the company upon completion of the qualifying transaction; and (vi) approval of RSM Canada LLP as auditor of the company following the completion of the qualifying transaction, each as further detailed in the management information circular of Apolo dated Jan. 20, 2026, as amended on Feb. 23, 2026, were approved by shareholders of Apolo.

We seek Safe Harbor.